Global X Management Company’s Abiomed Inc ABMD Stock Holding History

Global X Management Company’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$1.2M	Sell	2,921 -559	-16%	-$203K	0.02%	415
2018 Q1	$1.01M	Buy	3,480 +3,028	+670%	+$767K	0.02%	417
2017 Q4	$85K	Buy	452 +102	+29%	+$19K	﹤0.01%	870
2017 Q3	$59K	Buy	350 +50	+17%	+$7.56K	﹤0.01%	915
2017 Q2	$43K	Buy	300 +203	+209%	+$27.3K	﹤0.01%	987
2017 Q1	$12K	Buy	97 +3	+3%	+$348	﹤0.01%	1125
2016 Q4	$11K	Buy	94 +2	+2%	+$232	﹤0.01%	1032
2016 Q3	$12K	Hold	92	–	–	﹤0.01%	996
2016 Q2	$10K	Buy	+92	New	+$9.15K	﹤0.01%	893

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Global X Management Company's ABMD Position: Q2 2018 in Review

Global X Management Company reduced its Abiomed Inc (ABMD) stake by 16% in Q2 2018, selling an estimated $203K and leaving 2,921 shares worth $1.2M. The position accounts for 0.02% of the portfolio, ranked #415.

Global X Management Company first reported a position in ABMD in Q2 2016 and has held it in 9 quarters since. 527 funds tracked by Wall St. Rank hold ABMD as of Q2 2018.

Global X Management Company held 2,921 shares of Abiomed Inc worth $1.2M as of Q2 2018.
Global X Management Company sold 559 Abiomed Inc shares in Q2 2018, an estimated $203K.
Abiomed Inc made up 0.02% of Global X Management Company's portfolio in Q2 2018, its #415 holding.
Global X Management Company first reported a position in Abiomed Inc in Q2 2016 and has held it in 9 quarters since.
527 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.